Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Activation”

595 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 595 results

Not applicableStudy completedNCT00038675
What this trial is testing

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more
M.D. Anderson Cancer Center 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Looking for participantsNCT04996875
What this trial is testing

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Who this might be right for
Advanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)+1 more
Cogent Biosciences, Inc. 140
Very early researchStudy completedNCT05357833
What this trial is testing

Novel Imaging Markers in SPMS

Who this might be right for
Secondary Progressive Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis
University of Utah 11
Not applicableStudy completedNCT05281393
What this trial is testing

PrEP2Prevent An Online PrEP Navigation and Activation Intervention

Who this might be right for
HIV Infections
Children's Hospital Los Angeles 150
Not applicableStudy completedNCT02207075
What this trial is testing

Measuring Active Microglia in Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Weill Medical College of Cornell University 50
Testing effectiveness (Phase 2)WithdrawnNCT03168100
What this trial is testing

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas
Not applicableLooking for participantsNCT06131775
What this trial is testing

Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer

Who this might be right for
All Types of Solid Cancer
Hospices Civils de Lyon 300
Testing effectiveness (Phase 2)UnknownNCT03844763
What this trial is testing

Targeting the Tumor Microenvironment in R/M SCCHN

Who this might be right for
Head and Neck Cancer
Gruppo Oncologico del Nord-Ovest 71
Not applicableUnknownNCT00102934
What this trial is testing

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Very early researchActive Not RecruitingNCT07517068
What this trial is testing

The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude

Who this might be right for
HypoxemiaAcute Mountain Sickness (AMS)Inflammation+1 more
University of California, Riverside 19
Not applicableUnknownNCT03919643
What this trial is testing

BAFF and APRIL and RESPONSE TO BELIMUMAB in SLE

Who this might be right for
Systemic Lupus ErythematosusBAFF Polymorphism
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 200
Testing effectiveness (Phase 2)WithdrawnNCT03739606
What this trial is testing

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center
Not applicableNot Yet RecruitingNCT07393217
What this trial is testing

Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)
Sohag University 111
Early research (Phase 1)Study completedNCT00080431
What this trial is testing

Daclizumab to Treat HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT02081638
What this trial is testing

Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study

Who this might be right for
Human Immunodeficiency Virus
National Institute of Allergy and Infectious Diseases (NIAID) 53
Not applicableStudy completedNCT00001353
What this trial is testing

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00994175
What this trial is testing

A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

Who this might be right for
Severe, Refractory AsthmaAirway InflammationAirflow Obstruction
National Heart, Lung, and Blood Institute (NHLBI) 15
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Load More Results